Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Cash from Investing Activities: 2012-2025

Historic Cash from Investing Activities for Phibro Animal Health (PAHC) over the last 14 years, with Jun 2025 value amounting to -$288.7 million.

  • Phibro Animal Health's Cash from Investing Activities fell 617.20% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$306.8 million, marking a year-over-year decrease of 757.58%. This contributed to the annual value of -$288.7 million for FY2025, which is 499.01% down from last year.
  • Per Phibro Animal Health's latest filing, its Cash from Investing Activities stood at -$288.7 million for FY2025, which was down 499.01% from -$48.2 million recorded in FY2024.
  • Phibro Animal Health's Cash from Investing Activities' 5-year high stood at -$18.6 million during FY2021, with a 5-year trough of -$288.7 million in FY2025.
  • Its 3-year average for Cash from Investing Activities is -$137.0 million, with a median of -$74.0 million in 2023.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first spiked by 84.57% in 2021, then plummeted by 499.01% in 2025.
  • Phibro Animal Health's Cash from Investing Activities (Yearly) stood at -$18.6 million in 2021, then declined by 21.54% to -$22.6 million in 2022, then slumped by 227.77% to -$74.0 million in 2023, then soared by 34.89% to -$48.2 million in 2024, then slumped by 499.01% to -$288.7 million in 2025.